Dynamic analysis of circulating tumor DNA to predict the prognosis and monitor the treatment response of patients with metastatic triple-negative breast cancer: A prospective study
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dynamic analysis of circulating tumor DNA to predict the prognosis and monitor the treatment response of patients with metastatic triple-negative breast cancer: A prospective study
Authors
Keywords
-
Journal
eLife
Volume 12, Issue -, Pages -
Publisher
eLife Sciences Publications, Ltd
Online
2023-11-06
DOI
10.7554/elife.90198
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- In search of autophagy biomarkers in breast cancer: Receptor status and drug agnostic transcriptional changes during autophagy flux in cell lines
- (2022) Francesca Mascia et al. PLoS One
- Expression and prognostic values of ARID family members in breast cancer
- (2021) Jinfeng Zhang et al. Aging-US
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Genetic landscape of breast cancer and mutation tracking with circulating tumor DNA in Chinese women
- (2021) Yinghao Wang et al. Aging-US
- Blood-based genomics of triple-negative breast cancer progression in patients treated with neoadjuvant chemotherapy
- (2021) E. Ortolan et al. ESMO Open
- Dynamics of circulating tumor DNA during postoperative radiotherapy in patients with residual triple-negative breast cancer following neoadjuvant chemotherapy: a prospective observational study
- (2021) Haeyoung Kim et al. BREAST CANCER RESEARCH AND TREATMENT
- Modeling clonal structure over narrow time frames via circulating tumor DNA in metastatic breast cancer
- (2021) Zachary T. Weber et al. Genome Medicine
- Circulating Tumor DNA as a Predictive Marker of Recurrence for Patients With Stage II-III Breast Cancer Treated With Neoadjuvant Therapy
- (2021) Po-Han Lin et al. Frontiers in Oncology
- Homologous recombination DNA repair deficiency and PARP inhibition activity in primary triple negative breast cancer
- (2020) Neha Chopra et al. Nature Communications
- Improving long-term survival in diffuse intrinsic pontine glioma
- (2020) James Felker et al. Expert Review of Neurotherapeutics
- Landscape of circulating tumour DNA in metastatic breast cancer
- (2020) Andrew A. Davis et al. EBioMedicine
- Prognostic and predictive value of circulating tumor DNA during neoadjuvant chemotherapy for triple negative breast cancer
- (2020) Luca Cavallone et al. Scientific Reports
- Mutational characteristics determined using circulating tumor DNA analysis in triple‐negative breast cancer patients with distant metastasis
- (2020) Guohua Rong et al. Cancer Communications
- Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies
- (2019) Yi-Zhou Jiang et al. CANCER CELL
- Liquid Biopsy: General Concepts
- (2019) Geoffroy Poulet et al. ACTA CYTOLOGICA
- Tumor Heterogeneity Correlates with Less Immune Response and Worse Survival in Breast Cancer Patients
- (2019) Kerry-Ann McDonald et al. ANNALS OF SURGICAL ONCOLOGY
- Circulating Tumor DNA Sequencing Analysis of Gastroesophageal Adenocarcinoma
- (2019) Steven B. Maron et al. CLINICAL CANCER RESEARCH
- Gencore: an efficient tool to generate consensus reads for error suppressing and duplicate removing of NGS data
- (2019) Shifu Chen et al. BMC BIOINFORMATICS
- Liquid biopsy in ovarian cancer using circulating tumor DNA and cells: Ready for prime time?
- (2019) Du-Bois Asante et al. CANCER LETTERS
- Circulating tumor DNA as an early cancer detection tool
- (2019) Andrea Campos-Carrillo et al. PHARMACOLOGY & THERAPEUTICS
- OUP accepted manuscript
- (2018) BIOINFORMATICS
- Association of Cell-Free DNA Tumor Fraction and Somatic Copy Number Alterations With Survival in Metastatic Triple-Negative Breast Cancer
- (2018) Daniel G. Stover et al. JOURNAL OF CLINICAL ONCOLOGY
- Detection of Minimal Residual Disease Using ctDNA in Lung Cancer: Current Evidence and Future Directions
- (2018) Young Kwang Chae et al. Journal of Thoracic Oncology
- Concordance of Genomic Alterations by Next-Generation Sequencing in Tumor Tissue versus Circulating Tumor DNA in Breast Cancer
- (2017) Young Kwang Chae et al. MOLECULAR CANCER THERAPEUTICS
- Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
- (2017) Zachary R. Chalmers et al. Genome Medicine
- Triple-negative breast cancer has worse overall survival and cause-specific survival than non-triple-negative breast cancer
- (2016) Xiaoxian Li et al. BREAST CANCER RESEARCH AND TREATMENT
- Histone variant H3F3A promotes lung cancer cell migration through intronic regulation
- (2016) Seong-Min Park et al. Nature Communications
- Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy
- (2016) C. Alix-Panabieres et al. Cancer Discovery
- Elevated TGF-β1 and -β2 expression accelerates the epithelial to mesenchymal transition in triple-negative breast cancer cells
- (2015) Sangmin Kim et al. CYTOKINE
- Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer
- (2015) Isaac Garcia-Murillas et al. Science Translational Medicine
- Wnt modulates MCL1 to control cell survival in triple negative breast cancer
- (2014) Lixin Yang et al. BMC CANCER
- Comprehensive Genomic Analysis Identifies Novel Subtypes and Targets of Triple-Negative Breast Cancer
- (2014) M. D. Burstein et al. CLINICAL CANCER RESEARCH
- Circulating tumor DNA and circulating tumor cells in metastatic triple negative breast cancer patients
- (2014) Jordan Madic et al. INTERNATIONAL JOURNAL OF CANCER
- Liquid Biopsies: Genotyping Circulating Tumor DNA
- (2014) Luis A. Diaz et al. JOURNAL OF CLINICAL ONCOLOGY
- Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA
- (2013) Muhammed Murtaza et al. NATURE
- Circulating Tumor DNA to Monitor Metastatic Breast Cancer
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- BTG2 inhibits the proliferation, invasion, and apoptosis of MDA-MB-231 triple-negative breast cancer cells
- (2013) Yan-jun Zhang et al. TUMOR BIOLOGY
- CONTRA: copy number analysis for targeted resequencing
- (2012) Jason Li et al. BIOINFORMATICS
- Clinical and biologic features of triple-negative breast cancers in a large cohort of patients with long-term follow-up
- (2012) L. Malorni et al. BREAST CANCER RESEARCH AND TREATMENT
- MATH, a novel measure of intratumor genetic heterogeneity, is high in poor-outcome classes of head and neck squamous cell carcinoma
- (2012) Edmund A. Mroz et al. ORAL ONCOLOGY
- Molecular Stratification of Triple-Negative Breast Cancers
- (2011) C. M. Perou ONCOLOGIST
- Triple-Negative Breast Cancer
- (2010) William D. Foulkes et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Sequence Alignment/Map format and SAMtools
- (2009) H. Li et al. BIOINFORMATICS
- Fast and accurate short read alignment with Burrows-Wheeler transform
- (2009) H. Li et al. BIOINFORMATICS
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now